Vinca alkaloids and analogues as anti-cancer agents: Looking back, peering ahead

E Martino, G Casamassima, S Castiglione… - Bioorganic & medicinal …, 2018 - Elsevier
Cancer still represents a “nightmare” worldwide, causing annually millions of victims.
Several antiproliferative molecules are currently used as drugs market and offer a …

Cancer drug resistance: an evolving paradigm

C Holohan, S Van Schaeybroeck, DB Longley… - Nature Reviews …, 2013 - nature.com
Resistance to chemotherapy and molecularly targeted therapies is a major problem facing
current cancer research. The mechanisms of resistance to'classical'cytotoxic …

Microtubule-binding agents: a dynamic field of cancer therapeutics

C Dumontet, MA Jordan - Nature reviews Drug discovery, 2010 - nature.com
Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an
important therapeutic target in tumour cells. Agents that bind to microtubules have been part …

[HTML][HTML] Gold nanoparticles as a drug delivery system for standard chemotherapeutics: A new lead for targeted pharmacological cancer treatments

M Yafout, A Ousaid, Y Khayati, IS El Otmani - Scientific African, 2021 - Elsevier
Despite the great progress in medical sciences, cancer is still a major health problem. Since
the majority of cancer treatment protocols include first-generation chemotherapeutic agents …

Microtubules as a target for anticancer drugs

MA Jordan, L Wilson - Nature reviews cancer, 2004 - nature.com
Highly dynamic mitotic-spindle microtubules are among the most successful targets for
anticancer therapy. Microtubule-targeted drugs, including paclitaxel and Vinca alkaloids …

Microtubules and their role in cellular stress in cancer

AL Parker, M Kavallaris, JA McCarroll - Frontiers in oncology, 2014 - frontiersin.org
Microtubules are highly dynamic structures, which consist of α-and β-tubulin heterodimers,
and are involved in cell movement, intracellular trafficking, and mitosis. In the context of …

Molecular mechanisms of drug resistance

DB Longley, PG Johnston - The Journal of Pathology: A Journal …, 2005 - Wiley Online Library
Resistance to chemotherapy limits the effectiveness of anti‐cancer drug treatment. Tumours
may be intrinsically drug‐resistant or develop resistance to chemotherapy during treatment …

Mechanisms of Taxol resistance related to microtubules

GA Orr, P Verdier-Pinard, H McDaid, SB Horwitz - Oncogene, 2003 - nature.com
Since its approval by the FDA in 1992 for the treatment of ovarian cancer, the use of Taxol
has dramatically increased. Although treatment with Taxol has led to improvement in the …

Taxanes, microtubules and chemoresistant breast cancer

BT McGrogan, B Gilmartin, DN Carney… - Biochimica et Biophysica …, 2008 - Elsevier
The taxanes, paclitaxel and docetaxel are microtubule-stabilizing agents that function
primarily by interfering with spindle microtubule dynamics causing cell cycle arrest and …

Nuclear export of proteins and drug resistance in cancer

JG Turner, J Dawson, DM Sullivan - Biochemical pharmacology, 2012 - Elsevier
The intracellular location of a protein is crucial to its normal functioning in a cell. Cancer cells
utilize the normal processes of nuclear-cytoplasmic transport through the nuclear pore …